T2 Biosystems

$2.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-4.05%) As of 5:48 PM UTC today

Why Robinhood?

You can buy or sell T2 Biosystems and other stocks, options, and ETFs commission-free!

About TTOO

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA. The listed name for TTOO is T2 Biosystems, Inc. Common Stock.

CEO
John J. Sperzel
Employees
151
Headquarters
Lexington, Massachusetts
Founded
2006
Market Cap
318.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.95M
High Today
$2.25
Low Today
$2.11
Open Price
$2.20
Volume
2.97M
52 Week High
$3.79
52 Week Low
$0.235

TTOO Earnings

-$0.35
-$0.23
-$0.12
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 4, After Hours
Preview Earnings Call

You May Also Like

OCTZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure